Metyrapone

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 4786 publications

Adrenal insufficiency diagnosis: new approaches to indeterminate baseline cortisol.

Adrenal insufficiency diagnosis: new approaches to indeterminate baseline cortisol.

Journal: Current opinion in endocrinology, diabetes, and obesity

Published: August 06, 2026

Therapeutic mechanism of combination of Epimedii Folium and Ligustri Lucidi Fructus for glucocorticoid synthesis-restricted asthma in rats

Therapeutic mechanism of combination of Epimedii Folium and Ligustri Lucidi Fructus for glucocorticoid synthesis-restricted asthma in rats

Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica

Published: July 02, 2026

Recurrent Cushing's disease due to postoperative seeding of tumor cells in the sphenoid sinus: a case report with review of the literature.

Recurrent Cushing's disease due to postoperative seeding of tumor cells in the sphenoid sinus: a case report with review of the literature.

Journal: Endocrine journal

Published: June 10, 2026

Cushing's syndrome and pregnancy: Clinical presentation and diagnosis.

Cushing's syndrome and pregnancy: Clinical presentation and diagnosis.

Journal: Vitamins and hormones

Published: June 03, 2026

Metyrapone-Associated Improvements in Health-Related Quality of Life in Cushing's Syndrome.

Metyrapone-Associated Improvements in Health-Related Quality of Life in Cushing's Syndrome.

Journal: European journal of endocrinology

Published: May 19, 2026

11-deoxycortisol, other hormones and pituitary function characteristics in the diagnosis of adrenal insufficiency in the overnight oral metyrapone test.

11-deoxycortisol, other hormones and pituitary function characteristics in the diagnosis of adrenal insufficiency in the overnight oral metyrapone test.

Journal: Endocrine connections

Published: April 28, 2026

Sustained shrinkage of bilateral adrenal adenomas during long-term osilodrostat therapy.

Sustained shrinkage of bilateral adrenal adenomas during long-term osilodrostat therapy.

Journal: European journal of endocrinology

Published: April 23, 2026

Case Report: a family presenting with β-adrenergic/vasopressin-responsive bilateral macronodular adrenal disease with an ARMC5 mutation treated with metyrapone monotherapy for more than 5 years.

Case Report: a family presenting with β-adrenergic/vasopressin-responsive bilateral macronodular adrenal disease with an ARMC5 mutation treated with metyrapone monotherapy for more than 5 years.

Journal: Frontiers in endocrinology

Published: April 10, 2026

Managing mild autonomous cortisol secretion (MACS): evaluating the role of medical treatment.

Managing mild autonomous cortisol secretion (MACS): evaluating the role of medical treatment.

Journal: Frontiers in endocrinology

Published: April 08, 2026

Cardiovascular effects of metyrapone treatment in patients with mild autonomous cortisol secretion: a secondary analysis.

Cardiovascular effects of metyrapone treatment in patients with mild autonomous cortisol secretion: a secondary analysis.

Journal: The Journal of clinical endocrinology and metabolism

Published: March 24, 2026

Innate anxiety in rats determines vulnerability to social fear conditioning and social fear memory.

Innate anxiety in rats determines vulnerability to social fear conditioning and social fear memory.

Journal: Psychoneuroendocrinology

Published: March 16, 2026

Metyrapone in the Management of Severe Hypercortisolism Secondary to Ectopic Cushing's Syndrome.

Metyrapone in the Management of Severe Hypercortisolism Secondary to Ectopic Cushing's Syndrome.

Journal: Case reports in endocrinology

Published: February 25, 2026

Showing 1-12 of 4,786

Last Updated: 09/26/2026